This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Ill-defined sites within the digestive system
CD2_BENIGN_DIGESTIVE_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum systematis digestorii loco male specificato
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Ill-defined sites within the digestive system
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Ill-defined sites within the digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 208 | 137 | 71 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 61.18 | 59.51 | 64.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 186
- Matched controls
- 1859
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
+∞
205.2
157
*
130
Kela drug reimbursment
Malignant tumour
+∞
25.6
24
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
50.0
22.0
26
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.6
19.4
31
22
21199
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Unspecified site
+∞
19.1
18
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
16.9
16
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
23.6
16.4
23
11
A04AA02
ATC
granisetron; systemic, transdermal
+∞
14.8
14
*
115
Kela drug reimbursment
Breast cancer
+∞
13.7
13
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
30.9
13.2
17
6
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
13.1
51
144
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
+∞
12.6
12
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
50.1
12.0
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.3
11.7
37
83
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.8
11.6
41
104
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.5
11.1
29
51
H02AB02
ATC
dexamethasone; systemic
19.3
10.9
16
9
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
A02BC02
ATC
pantoprazole; systemic
3.0
10.5
139
923
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
10.0
64
266
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
9.8
79
380
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
9.4
9
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
9.3
82
415
UJF32
NOMESCO Finland
Coloscopy
2.9
8.9
66
300
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.4
8.7
15
13
N02AX02
ATC
tramadol; systemic, rectal
2.6
8.7
95
538
WX402
NOMESCO Finland
General anaesthesia
3.6
8.5
40
131
L02BG04
ATC
letrozole; oral
94.1
8.5
9
*
JAH00
NOMESCO Finland
Laparotomy
10.2
8.5
16
17
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.4
8
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
8.4
8
*
2119X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Other and unspecified site[NEOPLASMA BENIGNUM ALIUD ORG DIGEST AL DEF SEU NUD]
+∞
8.4
8
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
5.8
8.3
23
44
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
8.2
64
295
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
83.2
7.5
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.3
7
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
7.3
7
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
7.3
7
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
31.3
7.2
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
7.0
48
203
B01AB05
ATC
enoxaparin; parenteral
2.5
6.9
66
339
K83.1
ICD-10 Finland
Obstruction of bile duct
41.6
6.8
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.2
6.8
20
42
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
9.2
6.7
13
15
R4110
NOMESCO Finland
Physiotherapy
2.6
6.6
56
266
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
72.2
6.5
7
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
72.2
6.5
7
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.9
6.4
20
45
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
JFB00
NOMESCO Finland
Partial resection of small intestine
27.7
6.3
8
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
6.1
44
192
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
59
94
8.37
37.81
4.4
1.3
13.9
2.7
ug/l
1.16
47
74
36
43
9.92
28.78
2.6
1.6
582.1
10.1
u/ml
0.50
28
32
60
156
5.00
22.44
3.7
2.4
6.6
5.3
umol/l
0.26
54
135
18
15
13.04
18.04
1.2
1.2
—
—
—
0
0
29
50
6.58
16.69
1.3
1.3
281.0
315.4
ug/g
0.28
20
24
45
117
4.63
16.50
2.9
1.9
0.2
0.2
g/l
0.48
45
104
128
691
3.22
15.07
6.6
3.2
35.2
35.7
g/l
0.48
121
631
19
7
29.65
14.55
4.4
1.0
4.9
5.4
nmol/l
—
19
7
46
136
4.06
14.15
3.1
2.1
34.5
30.0
u/l
0.46
46
110
96
510
2.64
10.56
3.7
2.5
34.4
30.8
u/l
0.44
91
485
100
544
2.61
10.45
3.5
2.0
62.1
56.1
u/l
0.76
93
497
128
792
2.60
10.11
7.3
5.2
1.2
1.2
mmol/l
0.26
106
689
112
710
2.25
7.60
7.9
4.8
1.2
1.2
mmol/l
0.19
107
634
80
442
2.32
7.55
3.4
2.8
0.2
0.6
e6/l
2.03
56
316
52
240
2.56
7.27
2.6
2.2
12.5
13.5
umol/l
0.46
46
212
127
863
2.21
7.07
17.1
6.2
4.0
4.3
e9/l
0.51
106
747
44
190
2.67
7.02
2.9
2.4
19.6
23.6
%
1.12
37
163
25
80
3.42
6.69
5.6
6.8
24.3
25.2
mmol/l
0.57
25
80
43
188
2.62
6.68
5.1
5.4
103.6
104.1
mmol/l
0.36
43
182
166
1280
2.47
6.55
13.2
5.1
85.2
76.1
u/l
1.41
161
1160
136
975
2.14
6.29
5.3
4.1
7.1
6.7
mmol/l
0.83
130
899
90
570
2.02
5.66
3.4
2.9
—
—
—
0
0
104
706
1.95
5.25
5.3
3.5
—
—
—
0
0
26
102
2.77
4.94
1.4
1.5
—
—
—
0
0
39
190
2.30
4.74
7.1
4.3
1.1
1.0
mmol/l
0.16
39
170
35
170
2.27
4.27
1.7
1.7
—
—
—
0
0
11
27
4.25
4.22
1.4
1.3
—
—
—
0
0
46
254
2.04
4.07
3.2
2.9
4.9
3.1
e6/l
0.17
17
123
44
239
2.07
4.06
1.8
1.7
29.7
29.2
s
0.28
44
232
56
336
1.91
3.90
3.4
3.7
181.2
87.5
ng/l
0.33
45
264
34
170
2.20
3.87
4.6
2.9
—
—
—
0
0
35
180
2.14
3.71
4.0
5.7
0.9
1.7
mmol/l
0.61
25
138
44
248
1.98
3.66
1.7
1.7
—
—
—
0
0
97
700
1.72
3.62
2.9
2.3
80.7
78.6
nmol/l
0.28
86
606
97
703
1.71
3.54
3.6
2.6
127.9
107.5
ug/l
0.56
90
638
33
169
2.13
3.54
1.7
1.6
—
—
—
0
0
10
27
3.84
3.39
1.8
1.4
—
—
—
0
0
46
273
1.88
3.27
3.2
2.7
0.6
1.0
e6/l
1.08
16
140
162
1369
1.83
3.25
32.7
14.3
13.9
13.6
%
2.02
157
1335
51
316
1.81
3.16
5.8
2.1
2.4
2.4
mmol/l
0.36
46
266
31
164
2.05
3.06
3.5
3.4
6.0
5.9
kpa
0.26
31
158
5
5
10.20
2.99
1.2
1.2
—
—
—
0
0
9
226
0.37
2.76
11.4
6.7
—
—
—
0
0
52
337
1.72
2.75
3.1
2.0
—
—
—
0
0
9
24
3.87
2.70
1.3
1.1
—
—
—
0
0
9
26
3.57
2.51
1.6
1.2
—
—
—
0
0
9
26
3.57
2.51
1.6
1.2
—
—
—
0
0
8
21
3.92
2.49
1.4
1.0
—
—
—
0
0
9
27
3.44
2.42
1.7
1.4
—
—
—
0
0
129
1067
1.55
2.40
4.5
3.0
64.2
46.7
u/l
0.99
120
987
58
405
1.60
2.28
2.9
2.1
3.5
3.1
mg/l
0.42
53
332
8
25
3.29
2.12
1.4
1.3
—
—
—
0
0
15
69
2.27
2.10
1.1
1.1
—
—
—
0
0
15
69
2.27
2.10
1.1
1.1
7.6
7.7
g/l
—
8
53
15
69
2.27
2.10
1.1
1.1
4.0
4.0
g/l
—
8
51
5
10
5.09
2.08
1.4
1.1
—
—
—
0
0
24
134
1.89
2.06
2.6
2.7
4.0
4.3
kpa
0.45
24
127
9
32
2.89
2.02
1.9
1.5
233.1
308.4
mu/l
—
9
32
14
64
2.27
1.99
1.1
1.1
3.1
3.1
g/l
—
8
52
7
21
3.41
1.98
1.4
1.1
59.3
59.0
u/l
—
7
14
185
1697
1.82
1.97
25.2
11.9
27.6
21.3
mg/l
1.64
159
1286
6
16
3.83
1.95
1.5
1.1
—
—
—
0
0
60
437
1.52
1.94
3.1
2.3
325.8
8294.6
umol/l
2.50
54
379
8
28
2.93
1.88
1.5
1.3
61.0
65.8
pmol/l
—
8
28
103
843
1.44
1.83
3.7
3.7
0.0
0.0
estimate
0.00
25
148
92
739
1.44
1.80
2.3
2.0
96.9
95.9
pmol/l
0.07
45
361
10
41
2.51
1.78
1.3
1.3
—
—
—
0
0
6
18
3.40
1.76
1.3
1.1
—
—
—
0
0
5
13
3.91
1.72
1.4
1.2
—
—
—
0
0
17
91
1.95
1.66
1.5
1.4
—
—
—
0
0
5
14
3.63
1.62
1.6
1.1
—
—
—
0
0
7
26
2.75
1.59
2.3
1.1
—
—
nmol/l
—
0
0
7
26
2.75
1.59
1.6
1.3
—
—
—
0
0
192
1802
1.85
1.58
25.4
14.6
139.3
139.8
mmol/l
1.98
187
1745
17
93
1.90
1.57
3.8
3.9
4.1
4.4
pmol/l
1.30
17
81
5
15
3.39
1.53
1.6
1.1
—
—
—
0
0
16
87
1.91
1.50
1.1
1.0
—
—
—
0
0
102
854
1.38
1.50
5.0
5.0
0.0
0.0
estimate
0.00
22
143
192
1807
1.81
1.49
25.9
14.6
4.0
4.0
mmol/l
0.78
187
1750
17
95
1.86
1.48
1.4
1.6
—
—
—
0
0
193
1820
1.84
1.47
27.0
14.2
80.8
76.4
umol/l
0.72
193
1820
102
866
1.35
1.33
3.9
3.7
0.0
0.0
estimate
0.00
24
146
46
343
1.44
1.30
2.1
1.6
1.3
1.1
mg/l
0.21
41
264
14
237
0.56
1.28
4.1
4.9
30.3
32.6
%
—
7
152
6
25
2.44
1.25
1.2
1.0
—
—
—
0
0
55
433
1.37
1.14
1.7
1.5
21.0
20.9
nmol/l
0.01
49
366
7
31
2.30
1.11
1.6
1.1
—
—
—
0
0
173
1614
1.43
1.11
25.0
11.1
77.1
77.4
ml/min/173m2
0.06
149
1278
7
33
2.16
1.06
2.3
3.5
—
—
—
0
0
7
35
2.03
1.01
1.3
1.2
0.6
1.0
nmol/l
—
7
28
7
37
1.92
0.95
4.0
1.7
25.7
24.6
mmol/l
—
7
29
47
374
1.33
0.91
1.3
1.3
0.5
1.9
u/ml
1.48
12
106
55
450
1.30
0.88
4.3
3.8
0.0
0.0
estimate
0.00
23
145
0
25
0.00
0.79
0.0
1.4
—
74.4
—
0
18
0
28
0.00
0.76
0.0
3.2
—
22.9
—
0
8
159
1496
1.27
0.72
27.5
13.1
37.9
40.0
%
1.78
115
1011
9
57
1.60
0.72
1.2
1.7
—
—
—
0
0
7
42
1.69
0.69
1.1
1.3
2.4
217.0
e6/l
—
7
35
31
243
1.32
0.68
1.5
1.4
—
—
—
0
0
190
1835
1.41
0.66
16.5
8.8
26.0
24.7
u/l
0.69
184
1753
32
255
1.30
0.63
2.7
2.6
0.8
0.7
ug/l
0.03
21
178
29
228
1.32
0.63
9.1
20.0
1.1
1.3
inr
—
5
39
75
669
1.19
0.54
4.0
3.7
—
—
—
0
0
53
463
1.19
0.48
5.1
3.9
2.0
2.0
ug/l
0.01
47
413
7
47
1.51
0.48
2.1
1.5
—
—
—
0
0
7
49
1.44
0.46
1.3
1.7
—
—
—
0
0
168
1736
0.83
0.43
4.2
4.7
1.5
1.5
mmol/l
1.35
153
1590
8
56
1.45
0.43
1.1
1.2
—
—
—
0
0
42
364
1.19
0.42
4.6
3.8
24.8
24.1
%
0.07
14
178
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
162
1677
0.85
0.41
3.7
4.2
1.2
1.3
mmol/l
1.35
150
1524
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
55
490
1.17
0.40
1.8
1.6
1.4
1.3
mmol/l
0.19
49
413
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
101
943
1.14
0.38
3.0
2.7
—
—
—
0
0
5
36
1.40
0.38
1.0
1.3
—
—
—
0
0
170
1750
0.84
0.37
4.3
4.7
4.5
4.7
mmol/l
1.59
155
1606
167
1617
1.17
0.35
5.2
4.8
1.9
1.9
mu/l
0.17
157
1459
12
91
1.34
0.34
2.5
2.2
1.1
1.2
%
0.15
12
91
140
1341
1.13
0.34
4.2
4.0
14.6
14.8
pmol/l
0.47
128
1209
31
270
1.17
0.30
1.5
1.4
—
—
—
0
0
7
56
1.26
0.29
1.1
1.2
—
—
—
0
0
16
130
1.25
0.29
1.7
1.9
72.4
62.3
ml/min/173m2
—
7
52
40
358
1.15
0.28
2.0
1.7
1200.5
1200.8
nmol/l
0.00
30
272
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
170
1665
1.12
0.20
6.7
6.2
41.1
40.4
mmol/mol
0.38
160
1546
34
310
1.12
0.19
1.2
1.3
17.2
12.6
u/ml
0.14
16
107
29
319
0.89
0.18
1.3
1.3
13.4
35.4
iu/ml
2.35
14
105
11
92
1.21
0.16
1.1
1.4
—
—
—
0
0
69
724
0.93
0.16
3.8
3.6
42.0
85.7
ng/l
0.42
46
518
10
117
0.85
0.13
1.5
1.9
—
—
—
0
0
176
1783
0.92
0.13
5.0
5.3
2.6
2.7
mmol/l
0.86
160
1628
14
125
1.13
0.10
1.5
1.6
—
—
—
0
0
13
116
1.13
0.09
1.0
1.1
392.5
139.0
iu/ml
—
6
49
176
1742
1.07
0.08
4.7
4.8
6.0
6.0
mmol/l
0.12
163
1579
5
64
0.78
0.08
1.6
2.0
—
—
—
0
0
7
67
1.05
0.08
1.3
1.8
—
—
—
0
0
40
387
1.04
0.05
2.1
1.7
398.8
434.1
pmol/l
0.49
30
313
10
108
0.92
0.03
1.5
1.7
—
—
—
0
0
11
106
1.04
0.00
3.5
3.3
5.4
5.2
kpa
0.33
11
95
55
553
0.99
0.00
2.8
2.9
1674.8
1081.9
ng/l
0.34
47
457
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
0.00
1.4
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
68.8
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
64
0.94
0.00
1.3
1.7
—
—
—
0
0
6
62
0.97
0.00
1.8
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
10.2
—
0
7
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
61
0.98
0.00
2.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_DIGESTIVE_NOS_EXALLC – Benign neoplasm: Ill-defined sites within the digestive system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).